0001231919-26-001141.txt : 20260903 0001231919-26-001141.hdr.sgml : 20260903 20260903150300 ACCESSION NUMBER: 0001231919-26-001141 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506(b) provides a "safer harbor" for a private offering FILED AS OF DATE: 20260903 DATE AS OF CHANGE: 20260903 EFFECTIVENESS DATE: 20260903 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Dravite Therapeutics, Inc. CENTRAL INDEX KEY: 0002133272 ORGANIZATION NAME: EIN: 394859793 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-596376 FILM NUMBER: 261358022 BUSINESS ADDRESS: STREET 1: 401 CAMBRIDGE STREET CITY: SAN FRANCISCO STATE: CA ZIP: 94134 BUSINESS PHONE: 650-269-3210 MAIL ADDRESS: STREET 1: 401 CAMBRIDGE STREET CITY: SAN FRANCISCO STATE: CA ZIP: 94134 D 1 primary_doc.xml X0708 D LIVE 0002133272 Dravite Therapeutics, Inc. 401 CAMBRIDGE STREET SAN FRANCISCO CA CALIFORNIA 94134 510-920-4145 DELAWARE None None Corporation true 2025 JOSEPH SUM C/O DRAVITE THERAPEUTICS, INC. 401 CAMBRIDGE ST SAN FRANCISCO CA CALIFORNIA 94134 Executive Officer Director SANDEEP KULKARNI C/O DRAVITE THERAPEUTICS, INC. 401 CAMBRIDGE ST SAN FRANCISCO CA CALIFORNIA 94134 Director BARBARA KOSACZ C/O DRAVITE THERAPEUTICS, INC. 401 CAMBRIDGE ST SAN FRANCISCO CA CALIFORNIA 94134 Director MATTHEW MOORE C/O DRAVITE THERAPEUTICS, INC. 401 CAMBRIDGE ST SAN FRANCISCO CA CALIFORNIA 94134 Executive Officer Director JEREMY GOLDBERG C/O DRAVITE THERAPEUTICS, INC. 401 CAMBRIDGE ST SAN FRANCISCO CA CALIFORNIA 94134 Director RISHI GUPTA C/O DRAVITE THERAPEUTICS, INC. 401 CAMBRIDGE ST SAN FRANCISCO CA CALIFORNIA 94134 Director Other Decline to Disclose 06b false 2026-08-21 false true false 0 52999992 52999992 0 false 11 0 0 0 false Dravite Therapeutics, Inc. /s/ Matthew Moore Matthew Moore President and CEO 2026-09-03